Plasmodium berghei: The antimalarial activity of albendazole in rats is mediated via effects on the hematopoietic system

Experimental Parasitology

Volumn 94, Issue 4, 2000, Pages 259-263

  Dow, G S ^a   O'hara, A J ^a   Newton, S C ^a   Reynoldson, J A ^a   Thompson, R C A ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

Albendazole; Antimalarial drugs; Aplastic anemia; Bone marrow; Hematopoiesis; Malaria; Plasmodium berghei; Rats; Reticulocytes

Indexed keywords

ALBENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; BONE MARROW APLASIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HEMATOPOIETIC SYSTEM; MALARIA; MALE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; RAT; TOXICITY;

EID: 0034042833     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.2000.4491     Document Type: Article

References (15)

1. Contini C., Colombo D., Cultrera R., Prini E., Sechi T., Angelici E., Cainpari R. Employment of terbinafine against Pneumocystis carinii infection in rat models. British Journal of Dermatology. 134:1996;30-32.
2. Delatour P., Benoit E., Besse S., Boukraa A. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica. 21:1991;217-221.
3. Dieckmann-Schuppert A., Franklin R. M. Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro. Cell Biology International Reports. 13:1989;207-214.
4. Dieckmann-Schuppert A., Franklin R. M. Mode of action of tubulozoles against Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy. 34:1990;1529-1534.
5. Dow G. S., Reynoldson J. A., Thompson R. C. A. Plasmodium berghei: In vivo efficacy of albendazole in different rodent models. Experimental Parasitology. 88:1998;154-156.
6. Dow G. S., Reynoldson J. A., Thompson R. C. A. Plasmodium berghei: Assessment of in vivo blood schizonticidal activity of antimalarial drugs in a rat malaria model. Experimental Parasitology. 1999.
7. Fernandez F. J., Rodriguez-Vidigal F. F., Ledesma V., Cabanillas Y., Vagace J. M. Aplastic anemia during albendazole treatment. American Journal of Haematology. 53:1996;53-54.
8. Horton R. J. Albendazole: A review of the pharmacology, pharmacokinetics, clinical efficacy and safety in hydatid disease. Uchino J., Sato N. Alveolar Echinococcosis: Strategy for Eradication of Alveolar Echinococcosis of the Liver. 1996;261-282 Fuji Shoin Sapporo.
9. Mojon M., Saura C., Roojee N., Tran Manh Sung R. Albendazole and thiabendazole in murine strongyloidiasis. Journal of Antimicrobial Chemotherapy. 19:1987;79-85.
10. Skinner T. S. Comparison of Albendazole and Artemisinin Drugs against Protozoa. 1993;Murdoch Univ. Western Australia.
11. Skinner-Adams T. S., Davis T. M. E., Manning L. S., Johnston W. A. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91:1997;580-584.
12. Stokol T., Randolph J. E., Nachbar S., Rodi C., Barr S. C. Development of bone marrow toxicosis after albendazole administration in a dog and cat. Journal of the American Veterinary Medical Association. 210:1997;1753-1756.
13. Taylor D. H., Morris L. D., Richards K. S., Reffin D. Echinococcus multilocularis: In vivo results of therapy with albendazole and praziquantel. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82:1988;611-615.
14. Theodorides V. J., Gyurik R. J., Kingsbury W. D., Parish R. C. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia. 32:1976;702-703.
15. Tvedten H., Grabski S., Frame L. Estimating platelet and leucocytes on canine blood smears. Veterinary Clinical Pathology. 17:1988;4-6.